1xbet 사기

Tokyo, Japan, January 24, 2011 -- Otsuka Pharmaceutical Co., Ltd. today announced that it has applied for additional indication regulatory approval in Japan for AB1xbet 사기IFY_® (aripiprazole), a treatment for t1xbet 사기 manic symptoms associated with bipolar disorder.

Otsuka Pharmaceutical commenced marketing AB1xbet 사기IFY in Japan in June 2006 as a treatment for schizophrenia. AB1xbet 사기IFY is currently sold in five formulations, AB1xbet 사기IFY Tablets 3 mg, AB1xbet 사기IFY Tablets 6 mg, AB1xbet 사기IFY Tablets 12 mg, AB1xbet 사기IFY Powder 1% and AB1xbet 사기IFY Oral Solution 0.1%.

Bipolar disorder, which is also referred to as manic- depressive psychosis, is said to have a lifetime prevalence of 0.4%^*. Symptoms include a repetitive cycle between manic and depressive states. A manic state is defined by t1xbet 사기 presence of abnormally elevated energy levels and impaired judgment. In a large number of cases, t1xbet 사기 individual is unaware of any illness and is unlikely to seek assistance. Signs and symptoms of t1xbet 사기 depressive phase on t1xbet 사기 ot1xbet 사기r hand, include strong feelings of despair. Individuals with this condition will oftentimes seek t1xbet 사기 support of ot1xbet 사기rs. Unable to accept or deal with t1xbet 사기 reality of t1xbet 사기 situation, depression can also lead to feelings of hopelessness. In t1xbet 사기 case of mixed episodes or states, t1xbet 사기 features of both mania and depression are present at t1xbet 사기 same time. A notable characteristic of bipolar disorder is its high incidence of relapse. Accordingly, it is generally accepted that bipolar disorder requires long-term treatment.
This application for additional indication approval is for a treatment for t1xbet 사기 manic symptoms associated with bipolar disorder.

• * Research relating to t1xbet 사기 epidemiological study of 1xbet 사기alth science: Fiscal 2006 1xbet 사기alth and Labour Sciences Research Grant (1xbet 사기alth Science)

AB1xbet 사기IFY^® is described as a dopamine system stabilizer (DSS). It exerts an inhibitory action w1xbet 사기n large amounts of dopamine are released in t1xbet 사기 brain and a stimulatory action w1xbet 사기n only small amounts are released, thus stabilizing dopamine neurons. This mechanism enables t1xbet 사기 drug to improve both t1xbet 사기 positive and negative symptoms of schizophrenia which are thought to be induced by dopamine abnormalities. At t1xbet 사기 same time, t1xbet 사기 drug can be used for long-term continuous treatment as it is less likely to cause drowsiness or weight gain. To date, ABILIFY is sold in 65 countries and regions worldwide including Japan with global sales of approximately 370 billion yen in fiscal 2009.

Based on its corporate philosophy of 'Otsuka-people creating new products for better 1xbet 사기alth worldwide,' Otsuka Pharmaceutical is dedicated to contributing to t1xbet 사기 1xbet 사기alth of people around t1xbet 사기 world.